MedPath

Haisco-USA Pharmaceuticals, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)

Phase 1
Completed
Conditions
Anesthesia; Adverse Effect
Cardiac Arrhythmia
Interventions
First Posted Date
2025-01-27
Last Posted Date
2025-01-30
Lead Sponsor
Haisco-USA Pharmaceuticals, Inc.
Target Recruit Count
48
Registration Number
NCT06795204
Locations
🇨🇳

Beijing Gobroad Boren Hospital, Beijing, China

Dose-Finding and Human Abuse Potential Study Of HSK3486 Injection In Nondependent, Recreational Central Nervous System Depressant Users

Phase 1
Completed
Conditions
General Anesthesia
Interventions
First Posted Date
2022-11-14
Last Posted Date
2023-10-13
Lead Sponsor
Haisco-USA Pharmaceuticals, Inc.
Target Recruit Count
42
Registration Number
NCT05614544
Locations
🇺🇸

ICON (LPRA) - Salt Lake, Salt Lake City, Utah, United States

Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery

Phase 3
Completed
Conditions
General Anesthesia
Interventions
First Posted Date
2022-08-03
Last Posted Date
2024-07-26
Lead Sponsor
Haisco-USA Pharmaceuticals, Inc.
Target Recruit Count
466
Registration Number
NCT05486416
Locations
🇵🇱

Uniwersytecki Szpital Kliniczny W Opolu, Opole, Poland

🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

🇺🇸

The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

and more 23 locations

Efficacy and Safety of HSK3486 Compared to Propofol for Adults Undergoing Elective Surgery With General Anesthesia

Phase 3
Completed
Conditions
General Anesthesia
Interventions
First Posted Date
2022-07-28
Last Posted Date
2024-10-29
Lead Sponsor
Haisco-USA Pharmaceuticals, Inc.
Target Recruit Count
400
Registration Number
NCT05478174
Locations
🇺🇸

Phoenix Clinical Research, Tamarac, Florida, United States

🇺🇸

Chesapeake Research Group, Llc, Pasadena, Maryland, United States

🇺🇸

The Ohio State University Wexner Medical Center, Columbus, Ohio, United States

and more 20 locations

Efficacy and Safety of HSK3486 Compared to Propofol in Induction of General Anesthesia in Adults Having Elective Surgery

Phase 3
Completed
Conditions
Anesthesia
Interventions
First Posted Date
2021-01-15
Last Posted Date
2023-10-06
Lead Sponsor
Haisco-USA Pharmaceuticals, Inc.
Target Recruit Count
255
Registration Number
NCT04711837
Locations
🇺🇸

Lotus Clinical Research, LLC, Pasadena, California, United States

🇺🇸

Phoenix Clinical Research, LLC, Tamarac, Florida, United States

🇺🇸

Plano Surgical Hospital, Plano, Texas, United States

and more 10 locations
© Copyright 2025. All Rights Reserved by MedPath